This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jun;152(8):2077.

doi: 10.1053/j.gastro.2016.10.049. Epub 2017 May 4.

Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport

Julie Assaraf¹, Nicolas Weiss², Dominique Thabut³

Affiliations

Affiliations

¹ Unité de Soins Intensifs d'Hépato-gastroentérologie, Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France.
² Brain Liver Pitié-Salpêtrière Study Group and Unité de Réanimation Neurologique, Fédération de Neurologie, Pôle des Maladies du Système Nerveux, Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France.
³ Unité de Soins Intensifs d'Hépato-gastroentérologie and Brain Liver Pitié-Salpêtrière Study Group, Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France.

PMID: 28478148
DOI: 10.1053/j.gastro.2016.10.049

Comment

Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport

Julie Assaraf et al. Gastroenterology. 2017 Jun.

. 2017 Jun;152(8):2077.

doi: 10.1053/j.gastro.2016.10.049. Epub 2017 May 4.

Authors

Julie Assaraf¹, Nicolas Weiss², Dominique Thabut³

Affiliations

¹ Unité de Soins Intensifs d'Hépato-gastroentérologie, Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France.
² Brain Liver Pitié-Salpêtrière Study Group and Unité de Réanimation Neurologique, Fédération de Neurologie, Pôle des Maladies du Système Nerveux, Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France.
³ Unité de Soins Intensifs d'Hépato-gastroentérologie and Brain Liver Pitié-Salpêtrière Study Group, Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France.

PMID: 28478148
DOI: 10.1053/j.gastro.2016.10.049

No abstract available

PubMed Disclaimer

Comment in

Reply.
Tsai CF, Chen MH, Wang YP, Lu CL. Tsai CF, et al. Gastroenterology. 2017 Jun;152(8):2077-2078. doi: 10.1053/j.gastro.2017.05.007. Gastroenterology. 2017. PMID: 28552402 No abstract available.

Comment on

Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF, Chen MH, Wang YP, Chu CJ, Huang YH, Lin HC, Hou MC, Lee FY, Su TP, Lu CL. Tsai CF, et al. Gastroenterology. 2017 Jan;152(1):134-141. doi: 10.1053/j.gastro.2016.09.007. Epub 2016 Sep 14. Gastroenterology. 2017. PMID: 27639806

Similar articles

Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
Weiss N, Rosselli M, Mouri S, Galanaud D, Puybasset L, Agarwal B, Thabut D, Jalan R. Weiss N, et al. Metab Brain Dis. 2017 Apr;32(2):369-376. doi: 10.1007/s11011-016-9916-9. Epub 2016 Oct 11. Metab Brain Dis. 2017. PMID: 27730496
Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?
Khan MA, Cholankeril G, Howden CW. Khan MA, et al. Gastroenterology. 2017 Jun;152(8):2076. doi: 10.1053/j.gastro.2016.10.050. Epub 2017 May 4. Gastroenterology. 2017. PMID: 28478154 No abstract available.
Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast.
Khan MA, Cholankeril G, Howden CW. Khan MA, et al. Hepatology. 2017 Jan;65(1):393. doi: 10.1002/hep.28858. Epub 2016 Nov 15. Hepatology. 2017. PMID: 27688049 No abstract available.
Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis.
Lachar J, Bajaj JS. Lachar J, et al. Semin Liver Dis. 2016 Sep;36(4):327-330. doi: 10.1055/s-0036-1593881. Epub 2016 Dec 20. Semin Liver Dis. 2016. PMID: 27997972 Review.
Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective.
Moriwaki H, Shiraki M, Iwasa J, Terakura Y. Moriwaki H, et al. J Gastroenterol Hepatol. 2010 May;25(5):858-63. doi: 10.1111/j.1440-1746.2010.06242.x. J Gastroenterol Hepatol. 2010. PMID: 20546438 Review.

See all similar articles

Cited by

Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis.
Kuan YC, Huang KW, Lin CL, Luo JC, Kao CH. Kuan YC, et al. J Clin Med. 2019 Jul 25;8(8):1108. doi: 10.3390/jcm8081108. J Clin Med. 2019. PMID: 31349746 Free PMC article.
TIPS and hepatic encephalopathy in patients with cirrhosis.
Bozon-Rivière P, Rudler M, Weiss N, Thabut D. Bozon-Rivière P, et al. Metab Brain Dis. 2025 Feb 4;40(2):117. doi: 10.1007/s11011-025-01541-w. Metab Brain Dis. 2025. PMID: 39903376 Review.
Current and future pharmacological therapies for managing cirrhosis and its complications.
Kockerling D, Nathwani R, Forlano R, Manousou P, Mullish BH, Dhar A. Kockerling D, et al. World J Gastroenterol. 2019 Feb 28;25(8):888-908. doi: 10.3748/wjg.v25.i8.888. World J Gastroenterol. 2019. PMID: 30833797 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations